Healthcare M&A Advisory Pharmaceutical

M&A Advisory

Lazard

Full Credential Description

Calliditas Therapeutics AB. Sweden. Announced Date 15/07/2021. Closed Date 15/07/2021. Deal value: $75m. Calliditas secures $75 million term loan facility. Industry: Calliditas Therapeutics AB is a biopharmaceutical company focused on developing treatments for rare kidney diseases.

Back to Search Contact Business